Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04207151 · ClinicalTrials.gov registry record · NA

Expanding PrEP By Embedding Unannounced SNAPS Navigators in High STI Testing Clinical Sites

A NA study of HIV and Sexually Transmitted Infection, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT04207151 is a NA study of HIV and Sexually Transmitted Infection that has completed, run by NYU Langone Health. The registered enrollment target is 200 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04207151, a NA study of HIV and Sexually Transmitted Infection, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to assess the impact of an intervention, known as SNAPS, to expand Preexposure Prophylaxis (PrEP) prescriptions at Health + Hospitals (H+H)/Bellevue. In addition, evaluating whether this intervention, ie SNAPS, helps patients get on PrEP and stay on PrEP to prevent STIs like HIV. PrEP is a medication that needs to be taken on a regular basis in order to be effective to prevent HIV transmission.

Interventions

  • BEHAVIORAL SNAPS intervention

Study Locations (1)

New York

  • NYU Langone - New York

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-07-22
Est. Completion 2023-01-09
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT04207151

The ClinicalTrials.gov registry entry for NCT04207151 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (54% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which SNAPS intervention is the first listed.

NCT04207151 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04207151 about?

NCT04207151 is a clinical study titled "Expanding PrEP By Embedding Unannounced SNAPS Navigators in High STI Testing Clinical Sites". The goal of this study is to assess the impact of an intervention, known as SNAPS, to expand Preexposure Prophylaxis (PrEP) prescriptions at Health + Hospitals (H+H)/Bellevue. In addition, evaluating whether this intervention, ie SNAPS, helps patients get on PrEP and stay on PrEP to prevent STIs lik...

What is the current status of trial NCT04207151?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2019-07-22. Estimated completion is 2023-01-09.

What conditions does trial NCT04207151 study?

This clinical trial studies the following conditions: HIV, Sexually Transmitted Infection.

What interventions are being tested in trial NCT04207151?

The interventions under investigation include: SNAPS intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04207151?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04207151 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.